Clinical Trial Update: A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy. [Phase 4]

View source ↗

Summary

Phase 4 trial update for neoadjuvant hormone therapy in advanced prostate cancer undergoing radical prostatectomy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Advanced Prostate Cancer | Phase 4 | Status: TERMINATED